MARKET

EKSO

EKSO

Ekso Bionics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.530
-0.080
-2.22%
After Hours: 3.600 +0.07 +1.98% 16:49 05/28 EDT
OPEN
3.760
PREV CLOSE
3.610
HIGH
3.790
LOW
3.400
VOLUME
107.02K
TURNOVER
--
52 WEEK HIGH
23.55
52 WEEK LOW
2.250
MARKET CAP
20.63M
P/E (TTM)
-2.2386
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EKSO stock price target is 15.50 with a high estimate of 18.00 and a low estimate of 13.00.

EPS

EKSO News

More
96 Biggest Movers From Yesterday
Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019.
Benzinga · 1d ago
64 Biggest Movers From Yesterday
Gainers
Benzinga · 6d ago
51 Stocks Moving In Thursday's Mid-Day Session
Gainers Seneca Biopharma, Inc. (NASDAQ: SNCA) jumped 99% to $1.6350.
Benzinga · 05/21 17:18
CFIUS says no to Ekso Bionics' China JV
Ekso Bionics (NASDAQ:EKSO) slips 7.4% in premarket trade after the Committee on Foreign Investment in the United States determined the company must termina
seekingalpha · 05/21 17:11
Aegis Capital Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $13
Aegis Capital maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $15 to $13.
Benzinga · 05/21 14:13
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture
GlobeNewswire · 05/20 21:10
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture; Joint Venture Could Not Be Mitigated And Required The Termination Of The Company's Role With The Joint Venture
Benzinga · 05/20 20:13
Analysts Suggest Buying These 2 Falling Knives
GuruFocus.com · 05/18 16:34

Industry

Advanced Medical Equipment & Technology
+1.91%
Healthcare Equipment & Supplies
+1.61%

Hot Stocks

Symbol
Price
%Change

About EKSO

Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.
More

Webull offers kinds of Ekso Bionics Holdings Inc stock information, including NASDAQ:EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions.